PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26879145-9	2016	Recombinant human BMP-9-induced ALP activity was suppressed by SB203580, SP600125, and U0126, which are inhibitors of p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase 1/2 (ERK1/2), respectively.	pyrazolanthrone	73-81	growth differentiation factor 2	Homo sapiens	18-23	
23977991-4	2013	BMP9-induced osteogenic differentiation of MSCs was dramatically inhibited by JNKs inhibitor SP600125.	pyrazolanthrone	93-101	growth differentiation factor 2	Homo sapiens	0-4	
23977991-5	2013	Moreover, BMP9-activated Smads signaling was decreased by SP600125 treatment in MSCs.	pyrazolanthrone	58-66	growth differentiation factor 2	Homo sapiens	10-14	
28052093-4	2017	Our results showed that JNK inhibition by the specific inhibitor SP600125 or adenovirus expressing small interfering RNA (siRNA) targeting JNK (AdR-si-JNK) significantly decreased BMP9-induced gene and protein expression of early and late osteogenic markers, such as runt-related transcription factor 2 (Runx2), alkaline phosphatase (ALP), osteopontin (OPN), and osteocalcin (OCN), in hPDLSCs.	pyrazolanthrone	65-73	growth differentiation factor 2	Homo sapiens	180-184